Health
Prior SARS-CoV-2 infection enhances Johnson and Johnson Ad26.COV2.S vaccine immunogenicity – News-Medical.Net
A new study reports that the Johnson and Johnson vaccine against COVID-19 shows enhanced efficacy when administered to individuals…
A new study reports that the single-dose Johnson and Johnson Ad26.COV2.S vaccine against coronavirus disease 2019 (COVID-19) shows enhanced efficacy when administered to individuals with pre-existing antibodies against the severe acute respiratory syndrome…
Continue Reading
-
Noosa News22 hours agoCommissioner thanks police officer who threw a speed radar at a car
-
Noosa News20 hours agoNo matter what happens in his Origin debut, history beckons for rookie maroon Robert Toia
-
Noosa News20 hours agoDefence investigation finds Taipan pilot’s actions possibly prevented further fatalities in crash
-
General18 hours agoDairy farmers devastated by floods across parts of New South Wales